edgepedia

Society and history

127,669 articles

Inhibrx, Inc.

Inhibrx, Inc. was a clinical-stage biopharmaceutical company developing single-domain antibody therapeutics for cancer and orphan diseases; Sanofi acquired it in 2024 for its lead program INBRX-101.

Ini (pharaoh)

Ini, also written Iny or Inii, was a ruler of Thebes in ancient Egypt's Third Intermediate Period, reigning about 739–734 BC under the throne name Menkheperre.

Ini-Teshub

Ini-Teššub was a king of Carchemish in the 13th century BC, ruling as viceroy in Syria for the Hittite Great Kings and attested by a treaty with Ugarit.

Ini-Teshub II

Ini-Teshub (Initešub) was a king attested in 1100 BC in the annals of the Assyrian ruler Tiglath-Pileser I, commonly identified as a king of Carchemish in northern Syria.

Inibsharri

Inibsharri (Inib-Šarri) was a princess of Mari and daughter of King Zimrī-Lîm in the 18th century BC, twice married to vassal kings of the Habur region.

Inibshina

Inibshina (Inib-šīna) was an Old Babylonian princess of Ešnunna, daughter of King Daduša, known only from an inscribed balance weight found at Assur that may point to a marriage alliance with Assyria.

Iñigo Abbad y Lasierra

Iñigo Abbad y Lasierra (1745–1813) was a Spanish Benedictine priest and historian, remembered as the first historian of Puerto Rico; his 1782 Historia geográfica founded Puerto Rican historiography.

Iñigo U. Zobel

Iñigo U. Zobel (born 1957) is a Filipino businessman who has chaired Top Frontier Investment Holdings, San Miguel Corporation's largest shareholder, since 2008, and sits on San Miguel's board.

Inimabakesh

Inimabakeš was a Gutian ruler named in the Sumerian King List, credited with a 5-year reign over Sumer and Akkad after the fall of the Akkadian Empire.

Initial coin offering

An initial coin offering (ICO) is a form of crowdfunding in which a blockchain project sells its own cryptographic tokens to the public, beginning with MasterCoin in 2013.

Initial public offering

An initial public offering (IPO), also called a stock market flotation, is a company's first sale of shares to the public, typically with an exchange listing.

Initial public offering of Facebook

The initial public offering of Facebook, the Facebook IPO, was the largest technology IPO in U.S. history at the time, raising $16 billion on NASDAQ in May 2012.

Initial public offering of SpaceX

The initial public offering of SpaceX, its first sale of stock to public investors, closed in June 2026, raising about $85.7 billion on Nasdaq under the symbol SPCX.

Initialized Superclass

Initialized Superclass is the name of two venture capital funds of Initialized, a San Francisco seed firm, which raised $220 million in 2019 and 2021.

Initiation

Initiation, also known as an initiation ceremony or rite of passage, is a ritual marking a radical change in social or age status, found in all known cultures and structured through separation, liminality, and incorporation.

Initiative

Initiative (citizen initiative, ballot initiative): direct-democracy device letting voters propose laws or constitutional amendments by petition, used in 24 U.S. states since Oregon's 1902 Oregon System and in Switzerland and elsewhere.

Initiatives and referendums in the United States

Initiatives and referendums in the United States let citizens in roughly half the states vote directly on laws and constitutional amendments, a practice begun in South Dakota in 1898.

Injo of Joseon (이종)

Injo of Joseon (인조, Yi Jong, 1595–1649), 16th Joseon king (r. 1623–1649), enthroned by the 1623 Injo Banjeong coup against Gwanghaegun; his reign saw Yi Gwal's rebellion and the Manchu invasions of 1627 and 1636–1637.

Injong of Goryeo

Injong of Goryeo (인종), personal name Wang Hae, was the 17th king of Goryeo, reigning from 1122 to 1146, surviving two rebellions and commissioning the Samguk Sagi.

Injong of Joseon

Injong of Joseon (인종, 1515–1545) was the 12th king of the Joseon dynasty, whose seven-month reign in 1544–1545 was the dynasty's shortest; he exonerated victims of his father's 1519 literati purge.

Injuid dynasty

The Injuid dynasty was a minor Persian dynasty, founded by Sharaf al-Din Mahmud around 1325, that ruled Fars and neighboring provinces from Shiraz until falling to the Mozaffarids.

Injunction

Injunction: an equitable court order directing a party to do or stop doing something, used when damages are inadequate; forms include the TRO, preliminary injunction, and permanent injunction, with Roman and Chancery origins.

Inkatha Freedom Party

The Inkatha Freedom Party (IFP), founded by Mangosuthu Buthelezi as Inkatha yeNkululeko yeSizwe in 1975 and reconstituted in 1990, is a Zulu-anchored federalist South African party holding 18 National Assembly seats and KwaZulu-Natal opposition status.

Inke

Inke (映客) is a Chinese mobile live-streaming and social-entertainment company founded in Beijing in 2015 by Feng Yousheng, listed in Hong Kong in 2018 and renamed Inkeverse in 2022.

Inkishush

Inkishush, also known as Inkišush, was a Gutian ruler of Mesopotamia named in the Sumerian King List, which credits him with a six-year reign after Imta.

Inkitt

Inkitt, legally Inkitt GmbH, is a Berlin-based data-driven publishing and entertainment company founded in 2014 that uses algorithms to turn user-submitted stories into paid books, audio, and video.

Inline function

An inline function is a function marked with the inline keyword (C99/C++) or #[inline] (Rust). It hints the compiler to expand the body at call sites and, in C++, permits identical definitions across translation units; compilers may ignore the hint.

Inmar

Inmar is a Winston-Salem, North Carolina technology company founded in 1980 by John Whitaker that processes promotions, returns, and supply chain data for retailers, brands, and healthcare organizations.

InMode

InMode Ltd. is an Israeli aesthetic medical device company founded in 2008 as Invasix by Moshe Mizrahy and Dr. Michael Kreindel, making radiofrequency platforms for minimally invasive procedures.

Innate Pharma

Innate Pharma is a clinical-stage biotech developing antibodies and antibody-drug conjugates that recruit innate immune cells, especially natural killer cells, against cancer; its lead asset is IPH4502.